The TCGA database is classified into six subgroups on the basis of tumor patients’ immunological status: wound healing (immunological C1), Interferon (IFN)-gamma dominant (immune C2), inflammatory (immune C3), lymphocyte depleted (immune C4), immunological quotient (immune C5), and TGF-beta dominant (immune C6). The gene discussed is IFNG; the disease is neoplasm.